Matam. Vijay-Kumar, et.al., Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5., Science (New York, N.Y.), 2010, 328

http://rdf.ncbi.nlm.nih.gov/pubmed/20203013

Matam. Vijay-Kumar, et.al., Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5., Science (New York, N.Y.), 2010, 328

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal adipose tissue physiology_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0005666I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased circulating insulin level_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0002079I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• obese_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0001261I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased susceptibility to induced pancreatitis_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0004761I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased systemic arterial blood pressure_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0002842I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased systemic arterial diastolic blood pressure_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0006143I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased circulating triglyceride level_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0001552I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• abnormal gut flora balance_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0010377I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• abnormal physiological response to xenobiotic_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0008872I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased circulating cholesterol level_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0005178I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• abnormal glucose homeostasis_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0002078I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased systemic arterial systolic blood pressure_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0006144I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased susceptibility to induced colitis_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0008537I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• hypertension_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0000231I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased total body fat amount_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0010024I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• abnormal eating behavior_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0001431I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• insulin resistance_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0005331I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased susceptibility to autoimmune diabetes_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0004803I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased epididymal fat pad weight_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0009288I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• hepatic steatosis_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0002628I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• polyphagia_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0001433I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased body weight_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0001260I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv
• increased susceptibility to diet-induced obesity_Tlr5<tm1Flv>/Tlr5<tm1Flv>
  http://metadb.riken.jp/0005658I129S1SvC57BL6Tlr5tm1FlvTlr5tm1FlvTlr5tm1Flv